Jennifer Petter

Jennifer Petter

Company: Arrakis Therapeutics Inc.

Job title: Founder & Chief Innovation Officer

Seminars:

Examining the Intricacies of the Small Molecule Landscape to Influence Future Direction of RNA-Targeted Drug Discovery 4:30 pm

Where is the RNA-targeting small molecules field headed? Understanding the complexities and risks when developing new approaches to target RNA What are the shortcomings of using small molecules to target RNA that need to be understood and overcome?Read more

day: Day 1 PM

Panel Discussion: Overcoming Key Challenges to Improve Drug Design & Discovery for Novel Approaches 3:30 pm

Navigating the current landscape of small molecules targeting RNA How can the unlimited potential to target RNA with small molecules be explored and exploited to develop novel approaches? What are the lessons from other modalities that can be leveraged to develop small molecules that target RNA? What needs to happen for this modality to become…Read more

day: Day 1 PM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.